[Banner_HD_02]

Home   •   About   •   Consultancy Portfolio   •   Consultancy Network & Partners   •   Sponsorship Activities   •   Privacy Policy | Datenschutzerklärung   •   Impressum – Contact & Business Data




Dr. Matthias Brunner, Drug Regulatory Affairs Consultant

Consultancy Portfolio – Core Areas of Service


• CMC regulatory strategies and support regarding pharmaceutical quality aspects of medicinal products for MAA/NDA, clinical trial applications (CTA/IMPD/IND) and developmental projects

• Writing and updating of chemical-pharmaceutical documentation (Module 3/2.3) and further regulatory CMC documents for all regulatory purposes

• Module 3/2.3 preparation in CTD/eCTD format, in required granularity for eCTD submission; Creation of EU 'Baseline Dossier'

• Assessment, review and gap analyses of Module 3/2.3 documents, creation of deficiency lists

• Regulatory CMC Management and Regulatory Change Management for active substances / drug substances and medicinal products / drug products

• Assessment of regulatory compliance

• Responding to deficiency letters of competent authorities

• Consolidation of dossiers (e.g. from fragments, past variations); Transformation/re-formatting of legacy chemical-pharmaceutical documentation

• Microbiological aspects and testing strategies for unpreserved dosage forms in multi-dose containers

• Special expertise in quality aspects of nasal, ophthalmic and auricular products; tablets, capsules and sterile parenterals


Printable Portfolio (PDF, 259 kB)